Sepsis Market Report 2026

Sepsis Market Overview

• Sepsis market size has reached to $1.02 billion in 2025 • Expected to grow to $1.55 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Impact Of Infectious Diseases On Health Complications • Market Trend: AI And Technology For Improved Disease Diagnosis And Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sepsis Market?

Sepsis is a life-threatening condition caused by the body's extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to fight the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death. The main types in the sepsis are diagnosis and therapeutics. Diagnosis focuses on detecting sepsis in patients through a range of tests and procedures aimed at identifying infections and assessing their severity. The pathogens involved include bacteria, viruses, and fungi. Various applications include severe sepsis, and septic shock and is utilized in hospitals, pathology labs, and reference laboratories.

What Is The Sepsis Market Growth Forecast?

The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.55 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to AI-assisted early detection, expansion of point-of-care monitoring, integration with EHR systems, advanced therapeutics for sepsis, global sepsis management guidelines adoption. Major trends in the forecast period include early sepsis detection tools, AI-powered risk scoring, point-of-care sepsis monitors, tele-icu integration, protocol-driven treatment solutions.

Global Sepsis Market Segmentation

1) By Type: Diagnosis, Therapeutics 2) By Pathogen: Bacterial, Viral, Fungal 3) By Application: Severe Sepsis, Septic Shock 4) By End User: Hospitals, Pathology, Reference Laboratories Subsegments: 1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods 2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options

What Is The Driver Of The Sepsis Market?

The increasing burden of infectious diseases is expected to drive the growth of the sepsis market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites invading the body. Common infectious diseases include tuberculosis, flu, ringworm, and malaria, which spread through contact, contaminated sources, or insect vectors. The incidence of infectious diseases is due to growth, globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis is a severe complication of infectious diseases that arises from the body's extreme response to infections, leading to widespread inflammation and potential organ failure. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency for public health, in 2023, the United States recorded 9,633 cases of tuberculosis (TB), marking a 15.6% rise from 8,332 cases reported in 2022. Therefore, the increasing burden of infectious diseases is driving the growth of the sepsis industry.

Key Players In The Global Sepsis Market

Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Asahi Kasei Corporation, Becton Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, DiaSorin S.p.A., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

Global Sepsis Market Trends and Insights

Major companies operating in the sepsis market are focusing on developing technologically advanced platforms, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes, ultimately aiming to reduce mortality rates and improve healthcare efficiency in sepsis management. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched its AI software platform, OpenDX, an innovative platform that combines AI-powered diagnostics with wearable biosensors, enabling healthcare providers to detect early signs of sepsis. This aids in sepsis diagnosis and has the potential to expand to other health conditions, highlighting the role of technology in diagnostics. Predicate’s chest sensor helps healthcare workers detect early sepsis signs, a challenging and often missed diagnosis.

What Are Latest Mergers And Acquisitions In The Sepsis Market?

In April 2024, Prenosis Inc., a US-based biotechnology research company, partnered with Roche Holding AG. With this partnership, Roche will distribute Prenosis' Sepsis ImmunoScore, an AI-driven software as a medical device designed to assist healthcare providers in rapidly diagnosing sepsis and predicting adverse outcomes, enhancing the management of sepsis in clinical settings. Roche Holding AG is a Switzerland-based pharmaceutical company that develops medications for oncology, immunology, infectious diseases, and other sectors.

Regional Outlook

North America was the largest region in the sepsis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sepsis Market?

The sepsis market includes revenues earned by entities by providing services such as blood culture testing, molecular diagnostics, biomarker testing, intravenous (IV) fluid management, organ support services, and tele-ICU services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sepsis Market Report 2026?

The sepsis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sepsis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.